MYC is not detected in highly proliferating normal spermatogonia but is coupled with CIP2A in testicular cancers.

Ventelä, Sami; Mäkelä, Juho-Antti; Sears, Rosalie C; Toppari, Jorma; Westermarck, Jukka.

Ventelä S; Department of Physiology, University of Turku; Department of Molecular and Medical Genetics and Knight Cancer Institute, Oregon Health and Science University; Centre for Biotechnology and Department of Pathology, University of Turku.
Mäkelä JA; Department of Physiology, University of Turku; Department of Molecular and Medical Genetics and Knight Cancer Institute, Oregon Health and Science University; Centre for Biotechnology and Department of Pathology, University of Turku.
Sears RC; Department of Physiology, University of Turku; Department of Molecular and Medical Genetics and Knight Cancer Institute, Oregon Health and Science University; Centre for Biotechnology and Department of Pathology, University of Turku.
Toppari J; Department of Physiology, University of Turku; Department of Molecular and Medical Genetics and Knight Cancer Institute, Oregon Health and Science University; Centre for Biotechnology and Department of Pathology, University of Turku.
Westermarck J; Department of Physiology, University of Turku; Department of Molecular and Medical Genetics and Knight Cancer Institute, Oregon Health and Science University; Centre for Biotechnology and Department of Pathology, University of Turku.

Matters (Zur) ; 20162016 Mar.

Article en En | MEDLINE | ID: mdl-29527532

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2016 Tipo del documento: Article